
Excellent discussion of GammaTile and the ROADS trial podcasts.apple.com/us/podcas…
✓Husband, dad, grandfather, lifelong learner, amateur brewer, outdoor enthusiast, Professor Radiation Oncology #Brainmet #radiosurgery #radonc

Excellent discussion of GammaTile and the ROADS trial podcasts.apple.com/us/podcas…

doi.org/10.1016/j.adro.2026.… Kudos Dr. Jim X. Leng @MuzamilArshad18 @chr_huang @EJVaios @PeterFecci @Docace911 @julian_hong & colleagues Multiinstitutional study 1383 patients LF 6 mo vs RN 8 mo after SRS MultiD determined RN vs LF (path confirmed 28% vs 47%)

Impact OS Radionecrosis and Local Recurrenc after SRS for brain met · Median OS LF 15 mo vs RN 40 mo · Median OS Symptomatic RN 32 mo vs Asym RN 63 mo

Excellent editorial by @EricLehrer Congratulations @DrJeffWeinberg @brandon_imber @Dr_N_Moss @KimberlyBHoang @patelnv @AlexandraPaulMD @LindseySloan19 & ROADS colleagues @stuxrt thoughts?

Editorial Randomized trial resected brain met Brachytherapy vs Post-Op SRS Incredible Surg Bed Control with Brachy (↑↑OS as well) Look forward to results NRG BN012 NRG BN012 pre vs. post-op SRS hopefully ↓↓ LMD ascopubs.org/doi/10.1200/JCO…

Kudos Dr. Roan @CHHsieh12 & colleagues @MayoRadOnc

Randomized Trial adjuvant RT Keloids · 13 Gy sup control & aesthetic outcomes · 9 Gy reasonable low tension sites redjournal.org/article/S0360…

Kudos @markmcdonaldmd @PeterGorayski @arpitchhabraMD @AnitaMahajanMD @W_Rongthong @marianneaznar T1 w/oGad &fat sat helpful in bone Isolated surgical tract failures <5% so don’t cover entire surgical pathway

Guidelines Skull Base Chordoma Contours CTVIntermediate 50Gy tumor bed + prev involved mucosa, entire clivus+5mm CTVHigh 74Gy/37 bone+musosa Tumor bed, dura in area prepontine tumor extension, GTV+5mm sciencedirect.com/science/ar…

Kudos Dr. Hong @ghjahng @Byoung_hkim & colleagues No diff amyoid PET btwn arms TNF-α levels favored 3Gy at 12 mo doi.org/10.1016/j.radonc.202…

Update Sham controlled Randomized Trial Low Dose Radiation Therapy Alzheimer’s Disease • Better function w/LDRT (Secondary Endpoints) • Small trial, further study needed

Kudos Dr. Rubino @HannaAlgattasMD @GAZenonosMD @drjfm_stanford @DrShaanRaza & Skull Base Chondrosarcoma Consortium colleagues 79 patients (44% post-RT, RT more freq used after STR)

Gr2 Base Skull Chondrosarcoma, is adjuvant RT needed? · Clear benefit RT after STR · Smaller #s, numerical benefit after GTR · Median OS Adjuvant RT 21 yr vs. Surgery alone 10 yr · MVA ↑↑ LC =homogeneous enhancement, petroclival, adjuvant RT, GTR doi.org/10.3171/2025.3.JNS24…

rdcu.be/A7z8XzWGWxza Kudos Dr. Yufan Yang @SeanSachdevMD & colleagues 51 patients Northwestern & Mayo Clinic 10 yr OS 94% Median age 26 yo Recurrences freq without adjuvant RT: 5Yr RFS GTR 61% vs 46% STR

Central Neurocytoma radiotherapy improves tumor control Multivariate analysis ↓↓ Recurrence free survival: Omission adjuvant RT (HR 9), STR (HR 5.7), younger age (HR 3.1), ↑↑ Ki-67 (HR 1.1) Salvage RT is effective, after 1st recurrence 5-year RFS 83%

Kudos Dr. Lee & Catholic University Korea Seoul Colleagues 8/9 had Brooker grade III 5/6 had pain relief